Am J Clin Nutr

1. CRIDER KS, Adisa O, Pfeiffer CM, Wang A, et al
   Prediabetes, Diabetes and Folate Status among U.S. Women of Reproductive Age: National Health and Nutrition Examination Survey (NHANES) 2011-March 2020.
   Am J Clin Nutr. 2026 Jan 10:101193. doi: 10.1016/j.ajcnut.2026.101193.
   

   >> Share

   
   

   
   Am J Nephrol

2. WAN M, Yi C, Wang Y, Qiu Y, et al
   A comparative analysis of left ventricular myocardial work in patients with diabetic and non?diabetic kidney disease after peritoneal dialysis.
   Am J Nephrol. 2026 Jan 15:1-19. doi: 10.1159/000550324.
   

   >> Share

   
   

   
   Am J Ophthalmol

3. KAKIHARA S, Fawzi AA
   Comment on: Choroidal-Derived Intraretinal Neovascularization Compensates for Diabetic Retinopathy Ischemia via Dual-Pathway Remodeling Post-Pan-Retinal Photocoagulation.
   Am J Ophthalmol. 2026 Jan 14:S0002-9394(26)00021.
   

   >> Share

   
   

   
   Ann Intern Med

4. 
   Correction: Comparison of an Energy-Reduced Mediterranean Diet and Physical Activity Versus an Ad Libitum Mediterranean Diet in the Prevention of Type 2 Diabetes.
   Ann Intern Med. 2026 Jan 13. doi: 10.7326/ANNALS-25-04192.
   

   >> Share

   
   

   
   BMC Ophthalmol

5. XU S, Zhang X, Jiang B, Sun D, et al
   Lipid-rich vitreous hemorrhage associated with lipemia retinalis in a young patient with proliferative diabetic retinopathy.
   BMC Ophthalmol. 2026 Jan 16. doi: 10.1186/s12886-026-04618.
   

   >> Share

   
   

   
   Br J Ophthalmol

6. FRANQUESA-GARCIA F, Romero-Nunez B, Martin-Pinardel R, De Zanet S, et al
   Artificial intelligence-based fluid quantification predicts clinical outcomes in diabetic macular oedema eyes treated with intravitreal dexamethasone implants: DIADEMA project.
   Br J Ophthalmol. 2026 Jan 16:bjo-2025-328172. doi: 10.1136/bjo-2025-328172.
   

   >> Share

   
   

   
   Circulation

7. ZHAO YT
   Letter by Zhao Regarding Article, "Oral Semaglutide and Cardiovascular Outcomes in People With Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the SOUL Randomized Trial".
   Circulation. 2026;153:e8-e9.
   

   >> Share

   
   

   
   Diabet Med

8. SIDKI AS, Highton PJ, O'Mahoney LL, Wilkinson TJ, et al
   Hybrid closed-loop insulin delivery improves glycaemic control compared with sensor-augmented pump therapy: A meta-analysis of 'free-living' randomised trials in type 1 diabetes.
   Diabet Med. 2026 Jan 13:e70210. doi: 10.1111/dme.70210.
   

   >> Share

   
   
9. TILDEN DR, Bergner E, Anifowoshe K, Garretson S, et al
   Qualitative care experiences of emerging adults with type 1 diabetes after transfer to adult care providers.
   Diabet Med. 2026 Jan 13:e70214. doi: 10.1111/dme.70214.
   

   >> Share

   
   

   
   Diabetes

10. JIA X, Zhang C, Waugh K, Miao D, et al
    Identifying Insulin Autoantibodies With Differential Risk in Type 1 Diabetes With a Novel Bridging ELISA.
    Diabetes. 2026 Jan 12:db250696. doi: 10.2337/db25-0696.
    

    >> Share

    
    

    
    Diabetes Care

11. WANG G, Ruczinski I, Larman HB, Gutierrez MJ, et al
    Impact of Maternal Diabetes in Pregnancy on Newborn IgG Antibody Repertoire and Infection Risk in the First Six Months of Life.
    Diabetes Care. 2026 Jan 12:dc250990. doi: 10.2337/dc25-0990.
    

    >> Share

    
    
12. ZAGANJOR I, Bardenheier BH, Barrett CE, Rincon-Guevara O, et al
    Correlates and Trends in Glucose Testing at Postpartum Checkups Among Women Diagnosed With Gestational Diabetes: Pregnancy Risk Assessment Monitoring System, 2016-2022.
    Diabetes Care. 2026 Jan 13:dc252175. doi: 10.2337/dc25-2175.
    

    >> Share

    
    
13. GAO M, Wang H, Li N, Li W, et al
    High Fasting Plasma Glucose in Early Pregnancy and Postpartum Diabetes in Chinese Women With Gestational Diabetes.
    Diabetes Care. 2026 Jan 13:dc252310. doi: 10.2337/dc25-2310.
    

    >> Share

    
    
14. KADIYALA N, Brennan A, Lumb A, Holt RIG, et al
    Relationship Between Laboratory-Measured HbA1c and Continuous Glucose Monitoring-Derived Glucose Management Indicator in Adults With Cystic Fibrosis-Related Diabetes.
    Diabetes Care. 2026 Jan 13:dc252936. doi: 10.2337/dc25-2936.
    

    >> Share

    
    
15. SAKR SM, Desai S, Medina-Inojosa J, Liu C, et al
    Soluble Urokinase Plasminogen Activator Receptor (suPAR) Mediates the Impact of Diabetes on Adverse Outcomes in Coronary Artery Disease.
    Diabetes Care. 2026 Jan 14:dc250940. doi: 10.2337/dc25-0940.
    

    >> Share

    
    
16. SQUIRES S, Katte JC, Dabelea D, Pihoker C, et al
    The Impact of Ancestry on Performance of Type 1 Diabetes Genetic Risk Scores: High Discrimination Performance Is Maintained in African Ancestry Populations, but Population-Specific Thresholds May Improve Risk Prediction.
    Diabetes Care. 2026 Jan 16:dc251833. doi: 10.2337/dc25-1833.
    

    >> Share

    
    
17. THOMSON RL, Martin G, Brown JD, Oakey H, et al
    A Comparison of Diet and Exercise During Pregnancy in Women With and Without Type 1 Diabetes Followed in the Environmental Determinants of Islet Autoimmunity (ENDIA) Study.
    Diabetes Care. 2026 Jan 16:dc252064. doi: 10.2337/dc25-2064.
    

    >> Share

    
    

    
    Diabetes Obes Metab

18. SACRE JW, Lundegard K, Mohammedi K, Carstensen B, et al
    Prediction of heart failure as the first major cardiovascular disease event in type 2 diabetes.
    Diabetes Obes Metab. 2026 Jan 13. doi: 10.1111/dom.70426.
    

    >> Share

    
    
19. RAMIREZ-OBERMAYER A, Tripolt NJ, Pferschy PN, Kojzar H, et al
    Impact of intermittent fasting on self-regulatory behaviour and sleep in participants with insulin-treated type 2 diabetes: A secondary analysis of the INTERFAST-2 randomised controlled trial.
    Diabetes Obes Metab. 2026 Jan 12. doi: 10.1111/dom.70469.
    

    >> Share

    
    
20. KATZ A, Shulkin A, Housni A, Roy-Fleming A, et al
    A systematic review of glucocorticoid use in type 1 diabetes: Glycaemic effects and clinical management strategies.
    Diabetes Obes Metab. 2026 Jan 12. doi: 10.1111/dom.70465.
    

    >> Share

    
    
21. MESSIER V, Ramsay T, Rabasa-Lhoret R, Sun CJ, et al
    The spectrum of exogenous insulin requirement in people living with type 1 diabetes: A cross-sectional analysis.
    Diabetes Obes Metab. 2026 Jan 12. doi: 10.1111/dom.70467.
    

    >> Share

    
    
22. BRILLINGER J, Filliter C, Salmasi S, Zapata-Bravo E, et al
    Long-acting insulin analogues and the risk of diabetic nephropathy among patients with type 2 diabetes: A population-based cohort study.
    Diabetes Obes Metab. 2026 Jan 12. doi: 10.1111/dom.70397.
    

    >> Share

    
    
23. CHOU YC, Weng SH, Cheng FS, Tseng CH, et al
    Unintentional periconceptional exposure to glucagon-like peptide-1 receptor agonists and adverse pregnancy outcomes: A nationwide cohort study in Taiwan.
    Diabetes Obes Metab. 2026;28:1420-1430.
    

    >> Share

    
    
24. XING X, Zhao L, Wang K, Wang Z, et al
    Therapeutic equivalence and switching between biosimilar and reference insulins: A systematic review and meta-analysis of randomised controlled trials.
    Diabetes Obes Metab. 2026;28:1371-1382.
    

    >> Share

    
    
25. ANAGNOSTAKIS F, Kokkorakis M, Nagarajan S, Anastasiou G, et al
    Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists for incident dementia: A retrospective multicohort study.
    Diabetes Obes Metab. 2026;28:1443-1452.
    

    >> Share

    
    
26. HEUBOECK E, Bhogal CS, Mandl M
    Heart matters: How glucose- and lipid-modulating drugs remodel epicardial adipose tissue accumulation, inflammatory patterns and browning.
    Diabetes Obes Metab. 2026;28:878-894.
    

    >> Share

    
    
27. BANDURA M, Piotrowska-Mieczkowska M, Hennig M, Gliwinski M, et al
    Safety and efficacy of the therapy with CD4 + CD25highCD127-T regulatory cells: When paediatric patient becomes adult.
    Diabetes Obes Metab. 2026;28:1392-1402.
    

    >> Share

    
    
28. VILSBOLL T, Stellfeld M, Aroda VR, Dandanell S, et al
    Assessment of thyroid cancer risk associated with glucagon-like peptide 1 receptor agonist use.
    Diabetes Obes Metab. 2026;28:1499-1507.
    

    >> Share

    
    
29. RIVELINE JP, Julla JB, Bonnemaison E, Joubert M, et al
    A nationwide 12-month observatory of automated insulin delivery shows improved glucose control, sustained adoption, and reduced acute severe events.
    Diabetes Obes Metab. 2026;28:1179-1190.
    

    >> Share

    
    
30. FERREIRA JP, Marques P, Anker SD, Butler J, et al
    Effects of SGLT2 inhibitors across the spectrum of albuminuria in cardiovascular-kidney-metabolic conditions: A pooled analysis of randomised trials.
    Diabetes Obes Metab. 2026;28:1105-1115.
    

    >> Share

    
    
31. BASSET-SAGARMINAGA J, De Block C, Norgaard K, O'Neal DN, et al
    Safety and glycaemic control during exercise with the MiniMed 780G: A narrative review of evidence from lab to real world.
    Diabetes Obes Metab. 2026;28 Suppl 1.
    

    >> Share

    
    
32. TSUR A, Hamtzany O, Pollack R, Cahn A, et al
    Risk of recurrent diabetic ketoacidosis following initiation of sodium-glucose co-transporter 2 inhibitors in patients with an insulin-deficient diabetes and prior diabetic ketoacidosis: An observational cohort study.
    Diabetes Obes Metab. 2026 Jan 13. doi: 10.1111/dom.70457.
    

    >> Share

    
    
33. CHONG MY, Eussen SJPM, van der Velde JHPM, de Galan BE, et al
    Reallocating morning physical activity to later-day activity and its association with type 2 diabetes incidence: The Maastricht Study.
    Diabetes Obes Metab. 2026 Jan 13. doi: 10.1111/dom.70438.
    

    >> Share

    
    
34. CHAI C, Chen S, Guan G, Cui Q, et al
    Comparative prognostic value of nine cardiorenal biomarkers for mortality among adults with prediabetes and diabetes.
    Diabetes Obes Metab. 2026 Jan 13. doi: 10.1111/dom.70470.
    

    >> Share

    
    

    
    Diabetologia

35. KARAKUS KE, Chesshir L, Walker S, Baschal EE, et al
    Teplizumab treatment for stage 2 type 1 diabetes: a real-world evaluation of metabolic and immunological outcomes.
    Diabetologia. 2026 Jan 15. doi: 10.1007/s00125-025-06646.
    

    >> Share

    
    
36. VERHOOG NJD, Africander D, Storbeck KH
    Sex steroids, SHBG and type 2 diabetes in women: what do we really know?
    Diabetologia. 2026 Jan 15. doi: 10.1007/s00125-025-06647.
    

    >> Share

    
    

    
    Invest Ophthalmol Vis Sci

37. ZHANG B, Sun Y, Jiang X, Hu Z, et al
    METTL16 Inhibits Lens Epithelial Cells Function in Diabetic Cataract via m6A-Modified DKK1-Mediated Wnt/beta-Catenin Signaling.
    Invest Ophthalmol Vis Sci. 2026;67:1.
    

    >> Share

    
    
38. LI X, Guo Z, Li C, Zhang S, et al
    Glutaredoxin 2 Protects Lens Epithelial Cells From Ferroptosis by Preventing HNRNPA2B1 S-Glutathionylation in Diabetes-Mediated Cataractogenesis.
    Invest Ophthalmol Vis Sci. 2025;66:58.
    

    >> Share

    
    

    
    J Autoimmun

39. DESALEGN D, Fischer S, Bedada Y, Freuer D, et al
    Autoimmunity to mental health: Risk of depression in type 1 diabetes and celiac disease patients - A systematic review, meta-analysis, and bias assessment.
    J Autoimmun. 2026;158:103524.
    

    >> Share

    
    

    
    J Clin Invest

40. AUSTIN G, Tomas A
    Signaling architecture of the glucagon-like peptide-1 receptor.
    J Clin Invest. 2026;136:e194752.
    

    >> Share

    
    
41. CARDOSO P, Dennis JM, Pearson ER
    GLP-1RA precision medicine in people with type 2 diabetes: current insights and future prospects.
    J Clin Invest. 2026;136:e194742.
    

    >> Share

    
    

    
    J Diabetes Complications

42. ZHANG JH, Hao JC, Chang DY, Zhao MH, et al
    Associations between diabetic retinopathy and disease severity of diabetic nephropathy in patients with type 2 diabetes.
    J Diabetes Complications. 2026;40:109256.
    

    >> Share

    
    

    
    JAMA

43. VOELKER R
    What Is Type 2 Diabetes?
    JAMA. 2026 Jan 15. doi: 10.1001/jama.2025.23179.
    

    >> Share

    
    
44. TILG H, Petta S, Stefan N, Targher G, et al
    Metabolic Dysfunction-Associated Steatotic Liver Disease in Adults: A Review.
    JAMA. 2026;335:163-174.
    

    >> Share

    
    

    
    Lancet

45. ABIZAID A, Mehran R, Oliva A, Chamie D, et al
    Abluminus DES+ sirolimus-eluting stent versus everolimus-eluting stent in patients with diabetes and coronary artery disease (ABILITY Diabetes Global): results from a multicentre, randomised controlled trial.
    Lancet. 2026 Jan 8:S0140-6736(25)02157-9. doi: 10.1016/S0140-6736(25)02157.
    

    >> Share

    
    

    
    Metabolism

46. LEANZA G, Faraj M, Cannata F, Viola V, et al
    Bone inflammation in postmenopausal women with type 2 diabetes or obesity in relation to Wnt signaling and bone strength.
    Metabolism. 2026 Jan 8:156492. doi: 10.1016/j.metabol.2026.156492.
    

    >> Share

    
    

    
    Nutr Metab (Lond)

47. XIE K, Zhang Y, Yu LJZ, Yu X, et al
    Effects of Japan tallow on gut microbiota in type 2 diabetic mice.
    Nutr Metab (Lond). 2026 Jan 11. doi: 10.1186/s12986-026-01079.
    

    >> Share

    
    

    
    Ophthalmology

48. SHETH VS, Schlottmann P, Lai TYY, Abreu F, et al
    Four-Year Outcomes of Faricimab in Diabetic Macular Edema: Results From the RHONE-X Extension Trial.
    Ophthalmology. 2026 Jan 12:S0161-6420(26)00004.
    

    >> Share

    
    

    
    PLoS One

49. NIVETHA S, Ghosh M
    Mathematical modeling and cost-effective intervention strategies for diabetes management: A data-driven and numerical analysis approach.
    PLoS One. 2026;21:e0339463.
    

    >> Share

    
    
50. ZHONG W, Xiong Y, Luo J, Ahmad S, et al
    Integrative GC-MS, network pharmacology, and molecular dynamics elucidate synergistic anti-diabetic mechanisms of Chongqing Citrus reticulata 'Dahongpao' volatile oil via multi-target stabilization.
    PLoS One. 2026;21:e0338723.
    

    >> Share

    
    
51. OKHOLM GT, Gronkjaer M, Rungby J, Mortensen EL, et al
    Type 2 diabetes and age-related cognitive decline over 40 years in Danish men-A cohort study based on the Danish Aging and Cognition (DanACo) cohort.
    PLoS One. 2026;21:e0340622.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share